DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 ...

Drug Authentication System for Export Formulations Shifts from DGFT to Health Ministry Under Drug Rules 1945

February 1, 2025

Circulars DGFT

DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 (formerly Para 2.90A of HBP 2015-2020) regarding Track and Trace system for export of drug formulations, exercising powers under Paragraphs 1.03 and 2.04 of Foreign Trade Policy 2023. The responsibility for implementing authentication systems for exported drug formulations now transfers to Ministry of Health and Family Welfare, to be administered under Drug Rules 1945. The withdrawal takes immediate effect, marking a significant shift in regulatory oversight of pharmaceutical exports from trade authorities to healthcare regulators.

View Source

← Previous Next →

DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 ...

Drug Authentication System for Export Formulations Shifts from DGFT to Health Ministry Under Drug Rules 1945

February 1, 2025

Circulars DGFT

You may also like:

Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments

Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments - Public Notice

Claim of exemption under notification no. 6/02-CE (serial No. 57) of a formulation made from two bulk drugs - Diphenoxylate Hydrochloride with Atropine Sulphate. - if a...

Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy. - The revised policy now mandates obtaining a No Objection...

This instruction revises the list of high-end and high-value used/refurbished medical equipment, other than critical care medical equipment, that can be imported into...

Amendment in Export Policy of APIs and formulations made from these APIs - Notification

This public notice amends Appendix 2Y of the Foreign Trade Policy 2023 to exempt goods imported under Advance Authorisation, EOU, and SEZ schemes from mandatory Quality...

Wrongful availment of benefit of Duty Drawback - export of spurious drugs - the evidence led satisfies that the appellant was a genuine manufacturer duly licensed to...

Online filing and processing of applications for export of Restricted items (Non-SCOMET) at DGFT HQ.

Violation of import conditions - actual user condition - the imported Bulk Drugs has not been utilized by the appellant in his own factory for further manufacture of...

This amendment modifies provisions regarding unutilized duty-free imported materials under Advance Authorizations. In case of shortfall in Export Obligation fulfillment,...

The circular issued by SEBI on April 05, 2024, addresses the utilization of Aadhaar-based e-KYC authentication services in the securities market. It highlights the...

The Public Notice No. 10/2024-25 issued by the Ministry of Commerce and Industry, Department of Commerce, Directorate General of Foreign Trade, introduces enabling...

The CESTAT held that customs authorities cannot question the discharge certificate issued by DGFT regarding fulfilment of export obligation under the EPCG License,...

Confiscation of the imported machinery under the EPCG scheme - the DGFT, by granting extension for fulfilment of export obligation, have condoned the delay in achieving...

Quick Updates: